Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OXACILLIN Cause Product use in unapproved indication? 15 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Product use in unapproved indication have been filed in association with OXACILLIN (Oxacillin). This represents 2.8% of all adverse event reports for OXACILLIN.

15
Reports of Product use in unapproved indication with OXACILLIN
2.8%
of all OXACILLIN reports
1
Deaths
11
Hospitalizations

How Dangerous Is Product use in unapproved indication From OXACILLIN?

Of the 15 reports, 1 (6.7%) resulted in death, 11 (73.3%) required hospitalization, and 3 (20.0%) were considered life-threatening.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OXACILLIN. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does OXACILLIN Cause?

Drug reaction with eosinophilia and systemic symptoms (69) Drug ineffective (61) Acute kidney injury (51) Rash (31) Pyrexia (29) Toxic epidermal necrolysis (28) Eosinophilia (25) Infection (21) Off label use (20) Drug-induced liver injury (16)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Which OXACILLIN Alternatives Have Lower Product use in unapproved indication Risk?

OXACILLIN vs OXALIPLATIN OXACILLIN vs OXAPROZIN OXACILLIN vs OXAZEPAM OXACILLIN vs OXCARBAZEPINE OXACILLIN vs OXITRIPTAN

Related Pages

OXACILLIN Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication OXACILLIN Demographics